These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35065029)

  • 1. Advancing research in autoimmune neuromuscular disorders.
    Sanders DB
    Lancet Neurol; 2022 Feb; 21(2):108-110. PubMed ID: 35065029
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy in autoimmune neuromuscular disorders.
    Gold R; Dalakas MC; Toyka KV
    Lancet Neurol; 2003 Jan; 2(1):22-32. PubMed ID: 12849298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of intravenous gammaglobulin in neuromuscular and other diseases.
    Bertorini TE; Nance AM; Horner LH; Greene W; Gelfand MS; Jaster JH
    Muscle Nerve; 1996 Mar; 19(3):388-91. PubMed ID: 8606709
    [No Abstract]   [Full Text] [Related]  

  • 4. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction.
    Liyanage Y; Hoch W; Beeson D; Vincent A
    Muscle Nerve; 2002 Jan; 25(1):4-16. PubMed ID: 11754179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular diseases account for a major burden in the field of neurological diseases in the wealthy part of the world.
    Léger JM
    Curr Opin Neurol; 2012 Oct; 25(5):521-2. PubMed ID: 22960497
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral nerve and neuromuscular disorders.
    Rosenbaum RB; Donaldson JO
    Neurol Clin; 1994 Aug; 12(3):461-78. PubMed ID: 7990785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotherapies of neuromuscular disorders.
    Briand JF; Roy MO; Mourlane F; André C; Loux N; Rougeau C; Toursel T; Braun S
    Rev Neurol (Paris); 2014 Dec; 170(12):799-807. PubMed ID: 25459122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of neurologic disorders.
    Ciavarella D; Wuest D; Strauss RG; Gilcher RO; Kasprisin DO; Kiprov DD; Klein HG; McLeod BC
    J Clin Apher; 1993; 8(4):242-57. PubMed ID: 7906690
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune muscular pathologies.
    Dalakas MC
    Neurol Sci; 2005 May; 26 Suppl 1():S7-8. PubMed ID: 15883700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
    Berger M; McCallus DE; Lin CS
    J Peripher Nerv Syst; 2013 Dec; 18(4):275-96. PubMed ID: 24200120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular Disorders and Pregnancy.
    Massey JM; Gable KL
    Continuum (Minneap Minn); 2022 Feb; 28(1):55-71. PubMed ID: 35133311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular Emergencies.
    Bucelli R; Harms MB
    Semin Neurol; 2015 Dec; 35(6):683-9. PubMed ID: 26595869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
    Gold R; Hartung HP; Toyka KV
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Aug; 63(8):1066-71. PubMed ID: 16908731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular disorders associated with hepatitis B virus infection.
    Stübgen JP
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):26-37. PubMed ID: 22361623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases.
    Nadeau JO; Bhibhatbhan A; McDougall D; Toth C
    Clin Neurol Neurosurg; 2010 Jul; 112(6):467-9. PubMed ID: 20227821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The First Decade of Journal of Neuromuscular Diseases: Supporting and Advancing the Rapidly Evolving Field of Translational Research.
    Lochmüller H; Bönnemann CG
    J Neuromuscul Dis; 2024; 11(1):1-3. PubMed ID: 38189763
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical management of neuromuscular disorders in intensive care.
    Damian MS; Wijdicks EFM
    Neuromuscul Disord; 2019 Feb; 29(2):85-96. PubMed ID: 30639065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic apheresis: where we've been and where we are going.
    Vogler WR
    Prog Clin Biol Res; 1982; 106():1-13. PubMed ID: 6757935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.